LI, NANXIN,HARRIS, JENNIFER L.,MCNAMARA, PETER,SUN, FANGXIAN
申请号：
CA2824092
公开号：
CA2824092A1
申请日:
2012.02.02
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The invention provides methods for using compounds of Formula (I) for treating an EML4-ALK+ mediated condition such as EML4-ALK+ non-small cell lung cancer, and optionally resistant to crizotinib； wherein R1, R2, R3, R4, R5 and R6 are as defined above.
